The Turkish Competition Board publishes its reasoned decision regarding anticompetitive practices in the pharmaceutical sector and provides explanations on the calculation of the fine after its first decision was annulled on appeal (Turkish Pharmacists Association)

KEYWORDS
Reference

Turkish Competition Board, Turkish Pharmacists Association, N°18-10/185-88, 5 April 2018 (Turkish)

A. Introduction The Competition Board (“Board”) has recently published its reasoned decision [1] in its reassessment of the Turkish Pharmacists Association (Türk Eczacıları Birliği) (“TPA”) case, following the annulment decision rendered by the 13th Chamber of the High State Court (“High State Court”). The High State Court’s ruling was made as a result of the TPA’s appeal against the Board’s earlier decision concerning the TPA’s practices, which examined allegations that the TPA had fixed pharmacies’ purchasing terms and conditions in non- market circumstances. Pursuant to the investigation, the Board found that the TPA had violated Article 4 of the Law No. 4054 on the Protection of Competition (“Law No. 4054”), and imposed an administrative monetary fine corresponding to 3% of the TPA’s revenues

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • ELIG Gürkaynak Attorneys-at-Law (Istanbul)
    Turkey 50 contributions 14802 visits

Quotation

Gönenç Gürkaynak, The Turkish Competition Board publishes its reasoned decision regarding anticompetitive practices in the pharmaceutical sector and provides explanations on the calculation of the fine after its first decision was annulled on appeal (Turkish Pharmacists Association), 5 April 2018, e-Competitions Bulletin April 2018, Art. N° 88012

Visites 150

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues